Discovery of Benzophenanthridine Alkaloids from <i>Zanthoxylum nitidum</i> That Target the MDM2–p53 Axis in NSCLC
<b>Background/Objectives:</b> Non-small cell lung cancer (NSCLC) accounts for about 85% of lung cancers and is a leading cause of cancer-related deaths worldwide. Pharmacological targeting of the p53–MDM2 interaction to activate wild-type p53 is a promising strategy for treating NSCLC that retain fu...
Salvato in:
| Autori principali: | , , , , , , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
MDPI AG
2026-05-01
|
| Serie: | Pharmaceuticals |
| Soggetti: | |
| Accesso online: | https://www.mdpi.com/1424-8247/19/6/814 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
